Clinical Trial COGAAML08B1
AAML08B1 - Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
- Protocol No. COGAAML08B1
- Open Date: 10/26/2011
- Staging: N/A
- Age Group: Children
- Scope: National
- Objective: Molecular features of TMD may influence outcome in Down syndrome patients and predict their risk of developing subsequent leukemia.
- Disease Sites: Pediatrics; Pediatric Leukemia
- Therapies: None Specified
- Drugs: None Specified
- Participating Institutions: Vanderbilt University
- National Clinical Trial ID: NCT00959283
- Secondary Protocol No: AAML08B1
Not provided. Please call for more information.